Table 2.
Subject characteristics
| Total (n=127) | COAST (n=86) | SARP (n=41) | Ages 8–12 (n=63) | Ages 13–15 (n=30) | Ages 16–18 (n=34) | |
|---|---|---|---|---|---|---|
| Age (years) | 12.9±3.4 | 12.8±13.2 | 13.1±3.6 | 10.0±1.5 | 14.7±2.0 | 16.8±0.8 |
| Gender (F:M) | 54:73 | 37:49 | 17:24 | 28:35 | 9:21 | 17:17 |
| Pre-BD-FEV1 (% predicted) | 101.1±15.9 | 102.7±16.5 | 97.6±14.1 | 102.0±16.9 | 99.8±16.0 | 100.7±14.2 |
| Pre-BD- FEV1/FVC (% predicted) | 92.8±8.5 | 93.6±7.6 | 91.3±10.3 | 93.5±7.6 | 91.8±8.8 | 92.6±9.8 |
| FEV1 reversibility (% predicted) | 6.4±8.2 | 5.7±6.7 | 8.0±10.7 | 5.5±8.3 | 6.9±7.3 | 7.8±8.9 |
| Pre-MR exam symptoms | 2 (1.6%) | 0 (0%) | 2 (4.9%) | 0 (0%) | 2 (6.7%) | 0 (0%) |
| Anxiety | 10 (7.9%) | 8 (9%) | 2 (4.9%) | 5 (7.9%) | 2 (6.7%) | 3 (8.8%) |
BD bronchodilator, COAST Childhood Origins of ASThma, F female, FEV1 forced expiratory volume-one second, FVC forced vital capacity, M male, SARP Severe Asthma Research Program